Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monish Jain

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Investigation|August 5, 2008
Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteinsDavid S Ziegler, Renee D Wright, Santosh Kesari, et al.
Clinical Drug Investigation|September 8, 2023
Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding StudyBulent Enis Sekerel, Haylene Nell, Istvan Laki, et al.
Journal of Medicinal Chemistry|April 6, 2021
Use of Intramolecular 1,5-Sulfur-Oxygen and 1,5-Sulfur-Halogen Interactions in the Design of <i>N</i>-Methyl-5-aryl-<i>N</i>-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,4-thiadiazol-2-amine SMN2 Splicing ModulatorsJake Axford, Moo Je Sung, John Manchester, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2016
Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitorsKatsumasa Nakajima, Myriam April, Jason T Brewer, et al.
The Journal of Infectious Diseases|April 12, 2026
A first-in-human phase 1 clinical study in healthy volunteers to assess the safety, tolerability and pharmacokinetics of EDI048, a novel promising agent to treat enteric cryptosporidiosisMonish Jain, Kristen Stevenson, Anais Cheblal, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
A new structural alert for benzimidazoles: 2,6-dimethylphenyl substituents increase mutagenic potential and time-dependent CYP3A4 inhibition riskYoungshin Kwak, Gary Coppola, Cornelia J Forster, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial TriglyceridesMichael H Serrano-Wu, Gary M Coppola, Yongjin Gong, et al.
The European Respiratory Journal|February 23, 2023
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthmaGail M Gauvreau, Jens M Hohlfeld, J Mark FitzGerald, et al.
Journal of Medicinal Chemistry|May 13, 2017
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in HumansKatsumasa Nakajima, Ricardo Chatelain, Kevin B Clairmont, et al.
Journal of Medicinal Chemistry|August 4, 2017
Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension ModelsKen Yamada, Julian Levell, Taeyong Yoon, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Investigation|August 5, 2008
Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteinsDavid S Ziegler, Renee D Wright, Santosh Kesari, et al.
Clinical Drug Investigation|September 8, 2023
Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding StudyBulent Enis Sekerel, Haylene Nell, Istvan Laki, et al.
Journal of Medicinal Chemistry|April 6, 2021
Use of Intramolecular 1,5-Sulfur-Oxygen and 1,5-Sulfur-Halogen Interactions in the Design of <i>N</i>-Methyl-5-aryl-<i>N</i>-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,4-thiadiazol-2-amine SMN2 Splicing ModulatorsJake Axford, Moo Je Sung, John Manchester, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2016
Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitorsKatsumasa Nakajima, Myriam April, Jason T Brewer, et al.
The Journal of Infectious Diseases|April 12, 2026
A first-in-human phase 1 clinical study in healthy volunteers to assess the safety, tolerability and pharmacokinetics of EDI048, a novel promising agent to treat enteric cryptosporidiosisMonish Jain, Kristen Stevenson, Anais Cheblal, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
A new structural alert for benzimidazoles: 2,6-dimethylphenyl substituents increase mutagenic potential and time-dependent CYP3A4 inhibition riskYoungshin Kwak, Gary Coppola, Cornelia J Forster, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial TriglyceridesMichael H Serrano-Wu, Gary M Coppola, Yongjin Gong, et al.
The European Respiratory Journal|February 23, 2023
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthmaGail M Gauvreau, Jens M Hohlfeld, J Mark FitzGerald, et al.
Journal of Medicinal Chemistry|May 13, 2017
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in HumansKatsumasa Nakajima, Ricardo Chatelain, Kevin B Clairmont, et al.
Journal of Medicinal Chemistry|August 4, 2017
Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension ModelsKen Yamada, Julian Levell, Taeyong Yoon, et al.
Pageof 3